logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Neurology and Therapy cover

Neurology and Therapy

IF4.8
Papers939
Citations2234
Journal Papers 925
Publication Date
delete
Narcolepsy and Idiopathic Hypersomnia Real-World Treatment Patterns and Changes in Alerting Agent Use After Low-Sodium Oxybate Initiation: A Retrospective Claims Analysis
deleteNeurology and Therapy
IF4.8
delete2026-10-06
delete0
deleteOAAI
deleteSarah C. Markt; Marisa Whalen; Jessica K. Alexander; Caroleen Drachenberg; Natalie Gavrielov-Yusim; Silky Beaty; Elizabeth M. Poole; John Kroner; Dionna Attinson; Shaina Desai; Jed Black; Michael J. Thorpy
deleteShare
deleteSave
Triple Preventive Therapy with OnabotulinumtoxinA, Fremanezumab, and Atogepant in Treatment-Resistant Chronic Migraine: A 52-Week Pilot Case Series (TRIPLE Cohort)
deleteNeurology and Therapy
IF4.8
delete2026-10-06
delete0
deleteOAAI
deleteMarina Romozzi; Luigi Francesco Iannone; Antonio Russo; Ian Finkelstein; Dineo Seabi; Adam Ahlden; Anne Hege Aamodt; Catello Vollono; Paolo Calabresi; Edoardo Caronna; Patricia Pozo-Rosich; Erling Andreas Tronvik; Christina Sundal
deleteShare
deleteSave
Predictors of Seizure Occurrence After Mild Cognitive Impairment and Alzheimer’s Disease in Older Adults in the Veterans Affairs Healthcare System: A Retrospective Cohort Study
deleteNeurology and Therapy
IF4.8
delete2026-10-06
delete0
deleteOAAI
deleteMyriam Abdennadher; Ying Wang; Joel Reisman; Wen Hu; Peter Morin; Dan R. Berlowitz; Brant Mittler; Amir Abbas Tahami Monfared; Quanwu Zhang; Weiming Xia
deleteShare
deleteSave
Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Adults of Hispanic or Latino Ethnicity: Post Hoc Analysis of Three Randomized, Placebo-Controlled Trials
deleteNeurology and Therapy
IF4.8
delete2026-10-06
delete0
deleteOAAI
deleteJulio R. Vieira; Meghan Fajardo; Chandra Abbott; Jessica Li; Michael T. Sellix
deleteShare
deleteSave
Real-world Treatment Patterns Among Patients with Generalized Myasthenia Gravis in the United States
deleteNeurology and Therapy
IF4.8
delete2026-10-06
delete0
deleteOAAI
deleteKavita Grover; Martin Cloutier; Geoffroy Coteur; Porpong Boonmak; Antoine C. El Khoury; Maryia Zhdanava; Anabelle Tardif-Samson; Yuxi Wang; Kavita Gandhi
deleteShare
deleteSave
Artificial Intelligence for Gadolinium-Sparing Detection of Active Multiple Sclerosis Lesions: A Structured Narrative Review
deleteNeurology and Therapy
IF4.8
delete2026-10-06
delete0
deleteOAAI
deleteElham Moases Ghaffary; Omid Mirmosayyeb; Saeedeh Mirbagheri
deleteShare
deleteSave
Time Course of Rimegepant Effect for Acute Treatment of Migraine in Adults Unsuitable for Triptans: Exploratory Endpoints from a Phase 4, Randomized, Double-Blind, Placebo-Controlled Study
deleteNeurology and Therapy
IF4.8
delete2026-10-03
delete0
deleteOAAI
deleteMichel Lanteri-Minet; Timothy Smith; Catherine Nalpas; Luz M. Ramirez; Alexandra Thiry; Shannin McCollum; Sara Ramaker; Robert Fountaine
deleteShare
deleteSave
Horizon Scanning of Multiple Sclerosis Expenditure in Italy (2025–2029): Updated Insights from the Oracle Model
deleteNeurology and Therapy
IF4.8
delete2026-10-03
delete0
deleteOAAI
deleteDiego Centonze; Massimiliano Calabrese; Eleonora Cocco; Roberta Di Turi; Andrea Marcellusi; Andrea Marinozzi; Maria Vittoria Azzi; Alessandro Carrera; Francesca Donnaloja; Francesco Patti
deleteShare
deleteSave
Impact of Oral Cladribine on TSPO-PET-Measurable Immune Cell Activation in Multiple Sclerosis
deleteNeurology and Therapy
IF4.8
delete2026-09-30
delete0
deleteOAAI
deleteOlli Rajalehto; Markus Matilainen; Jussi Lehto; Eveliina Honkonen; Mikko Koivumäki; Saara Wahlroos; Johan Rajander; Olavi Misin; Amelie Luoma; Sini Laaksonen; Anna Vuorimaa; Marcus Sucksdorff; Maija Saraste; Laura Airas
deleteShare
deleteSave
Perspectives of Adult Patients and Caregivers on the Management and Challenges Associated with Neurofibromatosis Type 1 and Plexiform Neurofibromas: A Multinational Qualitative Survey
deleteNeurology and Therapy
IF4.8
delete2026-09-30
delete0
deleteOAAI
deleteAyo Adeyemi; Susanna Burckhardt; Riccardo Buttarelli; Michelle Erdmann; Rosalie Ferner; Brendon Pommier; Geting Su; Hui Zhang; Abby Crites
deleteShare
deleteSave
From Biomarker Anchors to Disease-State Transitions: A Biologically Anchored Probabilistic Principal Component Analysis Framework for Alzheimer’s Disease Progression Modeling
deleteNeurology and Therapy
IF4.8
delete2026-09-28
delete0
deleteOAAI
deleteBabak Haji; Amir Abbas Tahami Monfared
deleteShare
deleteSave
Correction: Patient Experience with 10 mg Intranasally Administered Zavegepant as an Acute Treatment of Migraine Attacks: Qualitative Research Findings
deleteNeurology and Therapy
IF4.8
delete2026-09-25
delete0
deleteOAAI
deleteNoah Rosen; Heather Moran; Josh Coulter; Alexandra Kissling; William You; Lewis Kopenhafer; Kathleen Beusterien; Jason Isaacs; Karina Nakajima; Jessica Cirillo; Samantha Sweeney
deleteShare
deleteSave
Maintenance of Minimal Manifestation Status with Individualized-Interval Efgartigimod in Generalized Myasthenia Gravis: Study Protocol for a Single-Arm, Open-Label Clinical Trial
deleteNeurology and Therapy
IF4.8
delete2026-09-24
delete0
deleteOAAI
deleteTetsu Suzuki; Motoki Fujimaki; Kota Igari; Shogo Ohuchi; Izumi Mihashi; Takashi Hosaka; Ayako Shioya; Makoto Terada; Shinji Saiki
deleteShare
deleteSave
Comparative Efficacy of Rozanolixizumab with Efgartigimod or Intravenous Immunoglobulin in Generalized Myasthenia Gravis Using Matching Adjusted Indirect Comparisons
deleteNeurology and Therapy
IF4.8
delete2026-09-24
delete0
deleteOAAI
deleteVikalp Maheshwari; Carolina Barnett Tapia; Abhiroop Chakravarty; Jitender Takyar; Arju Dhawan; Saiju Jacob; April Betts
deleteShare
deleteSave
Comparative Efficacy of Zilucoplan Versus Intravenous Immunoglobulin, Eculizumab, and Ravulizumab Using Matching-Adjusted Indirect Comparisons
deleteNeurology and Therapy
IF4.8
delete2026-09-24
delete0
deleteOAAI
deleteApril Betts; Saiju Jacob; Abhiroop Chakravarty; Jitender Takyar; Arju Dhawan; Carolina Barnett Tapia; Vikalp Maheshwari
deleteShare
deleteSave
The Role of Neurologists in the Management of Uncontrolled Epilepsy in Spain: Opportunities for Optimization
deleteNeurology and Therapy
IF4.8
delete2026-09-22
delete0
deleteOAAI
deleteDavid García-Azorín; Luis Lobato; Javier Riancho; Juan J. Poza; Ángel Aledo-Serrano
deleteShare
deleteSave
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in Spain, Greece, and Portugal
deleteNeurology and Therapy
IF4.8
delete2026-09-21
delete0
deleteOAAI
deleteRaquel Yahyaoui; Argirios Dinopoulos; Francina Munell; José Pedro Vieira; Manuela A. Santos; David Gómez-Andrés; Grace McCarthy; Matthias Bischof; Michel A. Kroes; Dimitrios I. Zafeiriou
deleteShare
deleteSave
Benzodiazepines in Epilepsy: A US Perspective on Clinical Use, Pharmacology, Abuse Methods, and Public Health Considerations
deleteNeurology and Therapy
IF4.8
delete2026-09-17
delete0
deleteOAAI
deleteEnrique Carrazana; Joseph Sirven; John Stern; Barry Gidal; Andres M. Kanner; Adrian L. Rabinowicz
deleteShare
deleteSave
Treatment Preferences of Physicians of Pediatric Patients with Attention-Deficit/Hyperactivity Disorder in the United States and Canada: A Discrete Choice Experiment
deleteNeurology and Therapy
IF4.8
delete2026-09-15
delete0
deleteOAAI
deleteJeff Schein; Marjolaine Gauthier-Loiselle; Yan Meng; Maryaline Catillon; Beatrice Libchaber; Francesca Lee; Martin Cloutier; Ann Childress
deleteShare
deleteSave
Evaluation of Autonomic and Cognitive Functions in Patients with Essential Tremor
deleteNeurology and Therapy
IF4.8
delete2026-09-15
delete0
deleteOAAI
deleteEda Özsezen; Nevin Pazarci
deleteShare
deleteSave